Bio-Rad Labs (BIO) Posts Q4 Loss of $0.70/Sh
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $297.09 --0%
EPS Growth %: -30.7%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
PKE, LNN, More
EPS Growth %: -30.7%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of ($0.70), which does not compare to the analyst estimate of $1.03. Revenue for the quarter came in at $571.5 million versus the consensus estimate of $570.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
